256 related articles for article (PubMed ID: 6465016)
1. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
Saksena S; Rothbart ST; Shah Y; Cappello G
Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
[TBL] [Abstract][Full Text] [Related]
3. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Saksena S; Rothbart ST; Cappello G
Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
[TBL] [Abstract][Full Text] [Related]
5. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
6. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
Lavery D; Saksena S
Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
11. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
Reddy CP; Kuo CS; Jivrajka V
Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1055-62. PubMed ID: 6209624
[TBL] [Abstract][Full Text] [Related]
12. Evaluation by serial electrophysiologic studies of an abbreviated oral loading regimen of amiodarone.
Kennedy EE; Rosenfeld LE; McPherson CA; Batsford WP
Am J Cardiol; 1985 Nov; 56(13):867-71. PubMed ID: 3904386
[TBL] [Abstract][Full Text] [Related]
13. A comparison of standard and high-dose regimens for the initiation of amiodarone therapy.
Summitt J; Morady F; Kadish A
Am Heart J; 1992 Aug; 124(2):366-73. PubMed ID: 1636580
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia.
Hariman RJ; Gomes JA; Kang PS; El-Sherif N
Am Heart J; 1984 Jun; 107(6):1109-17. PubMed ID: 6720537
[TBL] [Abstract][Full Text] [Related]
15. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
Zhu J; Haines DE; Lerman BB; DiMarco JP
Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.
Wellens HJ; Brugada P; Abdollah H; Dassen WR
Circulation; 1984 Jan; 69(1):120-4. PubMed ID: 6689635
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
Jung W; Mletzko R; Manz M; Nitsch J; Lüderitz B
Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):778-88. PubMed ID: 7683805
[TBL] [Abstract][Full Text] [Related]
19. Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone.
Brembilla-Perrot B; Claudon O; Houriez P; Beurrier D; Suty-Selton C
Int J Cardiol; 2002 Apr; 83(1):47-55. PubMed ID: 11959384
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone.
Gomes JA; Kang PS; Hariman RJ; El-Sherif N; Lyons J
Am Heart J; 1984 Feb; 107(2):214-21. PubMed ID: 6695655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
